Details for Patent: 8,058,069
✉ Email this page to a colleague
Which drugs does patent 8,058,069 protect, and when does it expire?
Patent 8,058,069 protects ONPATTRO and is included in one NDA.
This patent has twenty-one patent family members in thirteen countries.
Summary for Patent: 8,058,069
Title: | Lipid formulations for nucleic acid delivery |
Abstract: | The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP. |
Inventor(s): | Yaworski; Edward (Maple Ridge, CA), Lam; Kieu (Surrey, CA), Jeffs; Lloyd (Delta, CA), Palmer; Lorne (Vancouver, CA), MacLachlan; Ian (Mission, CA) |
Assignee: | Protiva Biotherapeutics, Inc. (Burnaby, B.C., CA) |
Application Number: | 12/424,367 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,058,069 |
Patent Claim Types: see list of patent claims | Composition; Compound; | More… ↓ |
Drugs Protected by US Patent 8,058,069
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharms Inc | ONPATTRO | patisiran sodium | SOLUTION;INTRAVENOUS | 210922-001 | Aug 10, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,058,069
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2008342535 | ⤷ Subscribe | |||
Australia | 2009238175 | ⤷ Subscribe | |||
Canada | 2710713 | ⤷ Subscribe | |||
Canada | 2721333 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |